Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program. Gary R...

Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier. Scott A Jelinsky,...

Catherine Robbe Masselot, Camille Cordier, PharmD, Benjamin Marsac, Maria Nachury, Renaud Léonard, Boualem Sendid Published: 25 November...

Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease by Inducing Host Immune Disorders. Wei Peng, Xinhua Zhao,...

Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease. Sushma Chowdary...

An autologous colonic organoid-derived monolayer model to study immune: bacterial interactions in Crohn's disease patients. Hamish CK...

Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and...

Benjamin Langan Gordon, Jonathan S Galati, Stevie Yang, Randy S Longman, Dana Lukin, Ellen J Scherl, Robert Battat Published in Sep 2022,...

James J Ashton, Guo Cheng, Imogen S Stafford, Melina Kellermann, Eleanor G Seaby, J R Fraser Cummings, Tracy A F Coelho, Akshay Batra,...

Olga Maria Nardone, Rosanna Cannatelli, Subrata Ghosh, Marietta Iacucci Published: 12 October 2022 Abstract Endoscopic remission is now...

Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the...

Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool...